|
BOC Sciences
aflibercept ![]() Aflibercept, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/aflibercept/Aflibercept/pmc08409505-619-13-14 Average 91 stars, based on 1 article reviews
aflibercept - by Bioz Stars,
2026-11
91/100 stars
|
Buy from Supplier |
|
Eagle Biosciences
aflibercept elisa kit ![]() Aflibercept Elisa Kit, supplied by Eagle Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/aflibercept/Aflibercept+(Eyelea+%2C+Zaltrap+)+ELISA+Assay+Kit/pmc11614000-51-6-12 Average 93 stars, based on 1 article reviews
aflibercept elisa kit - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Regeneron inc
aflibercept eleya ![]() Aflibercept Eleya, supplied by Regeneron inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/aflibercept/aflibercept+eleya/pmc05727022-135-0-2 Average 90 stars, based on 1 article reviews
aflibercept eleya - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Procon GmbH
aflibercept sflt01 ![]() Aflibercept Sflt01, supplied by Procon GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/aflibercept/aflibercept+sflt01/pmc07352801-242-15-17 Average 90 stars, based on 1 article reviews
aflibercept sflt01 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Synbio Technologies LLC
cdna for aflibercept with a c-terminal flag tag and the same n-terminal signal peptide ![]() Cdna For Aflibercept With A C Terminal Flag Tag And The Same N Terminal Signal Peptide, supplied by Synbio Technologies LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/aflibercept/cdna+for+aflibercept+with+a+c+terminal+flag+tag+and+the+same+n+terminal+signal+peptide/pm37509549-50-1-18 Average 90 stars, based on 1 article reviews
cdna for aflibercept with a c-terminal flag tag and the same n-terminal signal peptide - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
SAS Safety
intravitreal aflibercept ![]() Intravitreal Aflibercept, supplied by SAS Safety, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/aflibercept/intravitreal+aflibercept/pm36309572-94-12-15 Average 90 stars, based on 1 article reviews
intravitreal aflibercept - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Regeneron inc
ocular medication aflibercept eylea ![]() Ocular Medication Aflibercept Eylea, supplied by Regeneron inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/aflibercept/ocular+medication+aflibercept+eylea/pmc10297733-190-3-7 Average 90 stars, based on 1 article reviews
ocular medication aflibercept eylea - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Regeneron inc
aflibercept eylea ![]() Aflibercept Eylea, supplied by Regeneron inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/aflibercept/aflibercept+eylea/pm37631054-244-0-5 Average 90 stars, based on 1 article reviews
aflibercept eylea - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Regeneron inc
anti-vegf agents aflibercept eylea ![]() Anti Vegf Agents Aflibercept Eylea, supplied by Regeneron inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/aflibercept/anti+vegf+agents+aflibercept+eylea/10__1097_slash_md__0000000000006406-25-10-12 Average 90 stars, based on 1 article reviews
anti-vegf agents aflibercept eylea - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Regeneron inc
aflibercept ![]() Aflibercept, supplied by Regeneron inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/aflibercept/aflibercept/pm39198703-234-37-30 Average 90 stars, based on 1 article reviews
aflibercept - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Regeneron inc
aflibercept (eylea ![]() Aflibercept (Eylea, supplied by Regeneron inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/aflibercept/aflibercept++eylea+antibody/pmc03749085-5-0-2 Average 90 stars, based on 1 article reviews
aflibercept (eylea - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Regeneron inc
aflibercept (vegf trap, registered trademark ![]() Aflibercept (Vegf Trap, Registered Trademark, supplied by Regeneron inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/aflibercept/aflibercept+vegf+trap/us08710187-222-42-49 Average 90 stars, based on 1 article reviews
aflibercept (vegf trap, registered trademark - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Science translational medicine
Article Title: Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses
doi: 10.1126/scitranslmed.abd3438
Figure Lengend Snippet: (A) Summary of NHP study design and key intraocular inflammation results. The indicated number of NHPs received bilateral intravitreal injections of AAV2.aflibercept or AAV2.aflibercept.io2 at 1 × 1011 vg or 5 × 1011 vg on Day 1, and intraocular inflammation was scored based on the SUN criteria system during the 12-week study. Group 6 and 7 animals received intramuscular injection of prophylactic systemic steroids on Days −1 and 6. Clinical uveitis was defined as AC or VC score of 3 or higher. A two-tailed Fisher’s Exact Test with stepdown Sidak adjustment was used to analyze number of animals that reached clinical uveitis while a two-tailed generalized linear model was used to analyze average time to reach clinical uveitis. No statistically significant differences were detected between groups. (B) Aflibercept concentrations (μg/mL) in NHP vitreous humors. Aflibercept concentrations were measured in NHP vitreous humor samples collected 12 weeks post-injection. For AAV-treated animals, animals 1 and 2 were male and animals 3 to 5 were female. For vehicle-treated animals, animal 1 was male and animals 2 and 3 were female. A univariate linear regression model with aflibercept expression as the outcome was used to compare vitreous aflibercept concentrations in vector-injected groups. No statistically significant differences were detected between groups.
Article Snippet: A standard curve was prepared for each run on each plate using purified
Techniques: Injection, Two Tailed Test, Expressing, Plasmid Preparation
Journal: Investigative Ophthalmology & Visual Science
Article Title: Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies
doi: 10.1167/iovs.65.14.1
Figure Lengend Snippet: The 4D-150 dual-transgene expression and function in vitro. ( A ) Schema of 4D-150, a dual-transgene anti-angiogenic AAV gene therapy product. ( B ) Analysis of VEGF-A protein neutralization in the medium of human RPE transduced with 4D-150 or control R100.CAG-GFP vector, data are mean ± SD, * P < 0.05, **** P < 0.0001 by 2-way ANOVA with Tukey's multiple comparison post hoc test. ( C ) Expression of mature anti-VEGF-C miRNA measured by quantitative reverse transcription PCR (RT-qPCR) from transduced human RPE (MOI = 1000) in response to 4D-150 treatment, data are mean ± SD, ** P < 0.005 by unpaired t test. ( D ) RT-qPCR analysis of VEGF-C transcript levels in transduced RPE (MOI = 1000), normalized to Ribosomal Protein L32 as the housekeeping control. Mean ±SD. ( E ) Analysis of secreted VEGF-C protein from transduced RPE (MOI = 1000). BLQ values are represented as “0”, data are mean ± SD. **** P < 0.0001 by unpaired t test. Analysis of ( F ) proliferation and ( G ) migration of HUVEC cultures in a Transwell system after electroporation with the respective plasmid construct ( N = 3, data are mean ± SD. ** P < 0.01 compared to shock (electroporation control), * P < 0.05 compared to shock, †† P < 0.01 compared to CAG-GFP by 1-way ANOVA with Tukey's multiple comparison post hoc test. AFLB, aflibercept; BLQ, below the limit of quantification; GFP, green fluorescent protein; HUVEC, human umbilical vein endothelial cells; ITR, inverted terminal repeats; MOI, multiplicity of infection; RLU, relative luciferase units; RPE, retinal pigment epithelium; VEGF, vascular endothelial growth factor.
Article Snippet: Free aflibercept was evaluated using the
Techniques: Expressing, In Vitro, Neutralization, Transduction, Control, Plasmid Preparation, Comparison, Reverse Transcription, Quantitative RT-PCR, Migration, Electroporation, Construct, Infection, Luciferase
Journal: Investigative Ophthalmology & Visual Science
Article Title: Design and Characterization of a Novel Intravitreal Dual-Transgene Genetic Medicine for Neovascular Retinopathies
doi: 10.1167/iovs.65.14.1
Figure Lengend Snippet: Aflibercept protein expression and laser-induced CNV lesions in primates following IVT administration of 4D-150 or control. ( A ) Secreted free aflibercept protein expression in the aqueous humor by treatment group 21 days post IVT administration ( n = 14 eyes per group) and prior to laser-induced CNV, data are mean ± SD. **** P < 0.0001 by 1-way ANOVA with Bonferroni's multiple comparisons. ( B ) Percentage of eyes with grade IV lesions 2 weeks post laser per treatment group. ** P < 0.005, * P < 0.01 compared to vehicle by Fisher's Exact Prob test. ( C ) Reduced CNV complex area with 4D-150 pretreatment at 4 weeks post laser. Data are mean ± SEM. CNV complex areas of the principal axis of each lesion were calculated for each treatment group. Pretreatment with all doses of 4D-150 resulted in significantly smaller mean CNV complex areas compared to vehicle. ** P < 0.005 by 2-way ANOVA followed by Tukey-Kramer HSD. AFLB, aflibercept; CNV, choroidal neovascularization; IVT, intravitreal.
Article Snippet: Free aflibercept was evaluated using the
Techniques: Expressing, Control
Journal: Health Policy OPEN
Article Title: The impact of external reference pricing on pharmaceutical costs and market dynamics
doi: 10.1016/j.hpopen.2023.100093
Figure Lengend Snippet: Price change of aflibercept by country and external reference pricing status Source : Authors’ analysis of data from the Pricentric ONE™ database (Eversana, Chicago, IL).
Article Snippet: For example, the
Techniques:
Journal: Drug Design, Development and Therapy
Article Title: Aflibercept in wet AMD: specific role and optimal use
doi: 10.2147/DDDT.S40215
Figure Lengend Snippet: Diagram showing the structure of the vascular endothelial growth factor receptor-1 and -2 and the structure of aflibercept (VEGF Trap-eye). Notes: Aflibercept (VEGF Trap-eye) is generated by a fusion that includes the second binding domain of vascular endothelial growth factor receptor (VEGFR)-1 and the third binding domain of VEGFR-2 attached to a FC fragment of a human IgG. Abbreviation: FC, fragment crystallizable region.
Article Snippet:
Techniques: Generated, Binding Assay
Journal: Drug Design, Development and Therapy
Article Title: Aflibercept in wet AMD: specific role and optimal use
doi: 10.2147/DDDT.S40215
Figure Lengend Snippet: Vascular endothelial growth factor binds to two vascular endothelial growth factor receptors which induces the angiogenic response by activating the tyrosine kinase. Notes: vascular endothelial growth factor receptor (VEGFR)-2 is shown. Aflibercept (VEGF Trap-eye) binds all vascular endothelial growth factor (VEGF) isoforms more tightly than their native receptors, thus preventing binding of VEGF to its cognate receptors.
Article Snippet:
Techniques: Binding Assay